AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
AXL是固有侵袭和化疗诱导侵袭的关键调节因子，并能预测早期结肠癌的不良临床预后。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-13-1354
Dunne, Philip D; McArt, Darragh G; Blayney, Jaine K; Kalimutho, Murugan; Greer, Samanda; Wang, Tingting; Srivastava, Supriya; Ong, Chee Wee; Arthur, Ken; Loughrey, Maurice; Redmond, Keara; Longley, Daniel B; Salto-Tellez, Manuel; Johnston, Patrick G; Van Schaeybroeck, Sandra
